Francisco J. Diez-Arroyo

Badajoz, EX, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 10 publications

Enhancing user experience with an automated insulin delivery system by upgrading to a next generation sensor.

Enhancing user experience with an automated insulin delivery system by upgrading to a next generation sensor.

Journal: Diabetes & vascular disease research

Published: February 25, 2026

Amelioration of user experiences and glycaemic outcomes with an Advanced Hybrid Closed Loop System in a real-world clinical setting.

Amelioration of user experiences and glycaemic outcomes with an Advanced Hybrid Closed Loop System in a real-world clinical setting.

Journal: Diabetes research and clinical practice

Published: May 11, 2021

Rapid Improvement in Time in Range After the Implementation of an Advanced Hybrid Closed-Loop System in Adolescents and Adults with Type 1 Diabetes.

Rapid Improvement in Time in Range After the Implementation of an Advanced Hybrid Closed-Loop System in Adolescents and Adults with Type 1 Diabetes.

Journal: Diabetes technology & therapeutics

Published: March 30, 2021

Prospective Analysis of the Impact of Commercialized Hybrid Closed-Loop System on Glycemic Control, Glycemic Variability, and Patient-Related Outcomes in Children and Adults: A Focus on Superiority Over Predictive Low-Glucose Suspend Technology.

Prospective Analysis of the Impact of Commercialized Hybrid Closed-Loop System on Glycemic Control, Glycemic Variability, and Patient-Related Outcomes in Children and Adults: A Focus on Superiority Over Predictive Low-Glucose Suspend Technology.

Journal: Diabetes technology & therapeutics

Published: December 20, 2019

New uses and formulations of glucagon for hypoglycaemia.

New uses and formulations of glucagon for hypoglycaemia.

Journal: Drugs in context

Published: May 09, 2019

Impact of Sensor-Augmented Pump Therapy with Predictive Low-Glucose Suspend Function on Glycemic Control and Patient Satisfaction in Adults and Children with Type 1 Diabetes.

Impact of Sensor-Augmented Pump Therapy with Predictive Low-Glucose Suspend Function on Glycemic Control and Patient Satisfaction in Adults and Children with Type 1 Diabetes.

Journal: Diabetes technology & therapeutics

Published: September 27, 2018

The Incremental Benefits of the Predictive Low-Glucose Suspend Function Compared to the Low-Glucose Suspend Function as Automation Against Hypoglycemia in Sensor-Augmented Pump Therapy.

The Incremental Benefits of the Predictive Low-Glucose Suspend Function Compared to the Low-Glucose Suspend Function as Automation Against Hypoglycemia in Sensor-Augmented Pump Therapy.

Journal: Journal of diabetes science and technology

Published: July 31, 2018

Optimal glycaemic control during caesarean section provided by sensor-augmented pump therapy with predictive low-glucose suspend function.

Optimal glycaemic control during caesarean section provided by sensor-augmented pump therapy with predictive low-glucose suspend function.

Journal: Acta diabetologica

Published: June 27, 2018

Differences in the mean amplitude of glycemic excursions calculated by two automated methods.

Differences in the mean amplitude of glycemic excursions calculated by two automated methods.

Journal: Diabetes technology & therapeutics

Published: October 29, 2013

Health related quality of life in type 1 diabetes mellitus

Health related quality of life in type 1 diabetes mellitus

Journal: Anales de pediatria (Barcelona, Spain : 2003)

Published: October 04, 2011

Showing 1-10 of 10

Last Updated: 09/26/2026